Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed

Blood. 2001 May 15;97(10):3321-2. doi: 10.1182/blood.v97.10.3321.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Clinical Trials as Topic*
  • Humans
  • Leukocyte Count*
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / drug therapy*
  • Neutrophils*